Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
British Journal of Cancer|April 7, 1998
Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancerA Knoop, P A Andreasen, J A Andersen, et al.
Acta Pathologica Et Microbiologica Scandinavica. Section A, Pathology|July 1, 1981
Metastases to the breast from extramammary carcinomasM Nielsen, J A Andersen, F W Henriksen, et al.
Cancer|July 15, 1995
Chromosome abnormalities in bilateral breast carcinomas. Cytogenetic evaluation of the clonal origin of multiple primary tumorsN Pandis, M R Teixeira, A M Gerdes, et al.
Breast Cancer Research and Treatment|January 1, 1996
Cytogenetic abnormalities in an in situ ductal carcinoma and five prophylactically removed breasts from members of a family with hereditary breast cancerM R Teixeira, N Pandis, A M Gerdes, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1989
Significance of incisional biopsy in breast carcinoma: results from a clinical trial with intended excisional biopsyS Watt-Boolsen, G Ottesen, J A Andersen, et al.
Ugeskrift for Laeger|August 12, 1991
[Adjuvant endocrine treatment of postmenopausal patients with breast cancer with high risk of recurrence. 5. Results from the DBCG (Danish Breast Cancer Cooperative Group) 77C randomized trial]C Rose, J A Andersen, K W Andersen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
A Danish randomized trial comparing breast-preserving therapy with mastectomy in mammary carcinoma. Preliminary resultsM Blichert-Toft, H Brincker, J A Andersen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 31, 1998
The importance of surgery and accurate axillary staging for survival in breast cancerD A Grabau, M B Jensen, M Blichert-Toft, et al.
Ugeskrift for Laeger|August 12, 1991
[Adjuvant chemotherapy in premenopausal and menopausal high-risk patients with breast cancer. 4. Results of the DBCG (Danish Breast Cancer Cooperative Group) 77B study]P Dombernowsky, J A Andersen, K W Andersen, et al.
Ugeskrift for Laeger|August 12, 1991
[Prognosis after surgical treatment of breast cancer. 3. The low-risk group of the DBCG (Danish Breast Cancer Cooperative Group)]C K Axelsson, J A Andersen, K W Andersen, et al.
Pageof 9